Molecular Genetics & Genomic Medicine (Jul 2022)

Molecular autopsy and clinical family screening in a case of sudden cardiac death reveals ACTN2 mutation related to hypertrophic/dilated cardiomyopathy and a novel LZTR1 variant associated with Noonan syndrome

  • Lilia Kraoua,
  • Hager Jaouadi,
  • Mohamed Allouche,
  • Ahlem Achour,
  • Hakim Kaouther,
  • Habib Ben Ahmed,
  • Lilia Chaker,
  • Faouzi Maazoul,
  • Fatma Ouarda,
  • Stéphane Zaffran,
  • Ridha M'rad

DOI
https://doi.org/10.1002/mgg3.1954
Journal volume & issue
Vol. 10, no. 7
pp. n/a – n/a

Abstract

Read online

Abstract Background Genetic cardiac diseases are the main trigger of sudden cardiac death (SCD) in young adults. Hypertrophic cardiomyopathy (HCM) is the most prevalent cardiomyopathy and accounts for 0.5 to 1% of SCD cases per year. Methods Herein, we report a family with a marked history of SCD focusing on one SCD young adult case and one pediatric case with HCM. Results For the deceased young adult, postmortem whole‐exome sequencing (WES) revealed a missense variant in the ACTN2 gene: c.355G > A; p.(Ala119Thr) confirming the mixed hypertrophic/dilated cardiomyopathy phenotype detected in the autopsy. For the pediatric case, WES allowed us the identification of a novel frameshift variant in the LZTR1 gene: c.1745delT; p.(Val582Glyfs*10) which confirms a clinical suspicion of HCM related to Noonan syndrome. Conclusion The present study adds further evidence on the pathogenicity of ACTN2: p. Ala119Thr variant in SCD and expands the mutational spectrum of the LZTR1 gene related to Noonan syndrome.

Keywords